| 摘要 |
<p>FIELD: medicine, oncology, urology. SUBSTANCE: invention relates to method for treatment of prostate tumors. For this purpose cetrorelix is administrated in the dose 0.5 mg/day as monotherapy or in combination with inhibitors of alpha-reductase or agents blocking adrenergic receptors. Method provides reduction of prostate volume and eliminates by-side effects of castration level of testosterone. EFFECT: enhanced effectiveness of treatment. 4 cl, 4 dwg, 2 ex</p> |
